BH Share Price Performance
฿0
-207.00 (-100.00%)
Price ฿0
Fair Value฿152.00
Share Pricen/a
Bumrungrad Hospital Public Company Limited Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 17 Fair Values set on narratives written by author
BH Community Narratives
AN
Fair Value ฿152 13.5% overvalued intrinsic discount
Middle East Instability And Rising Wages Will Hurt Performance
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
Fair Value ฿214.62 19.6% undervalued intrinsic discount
New Cancer Center And Robotic Surgery Will Expand Global Capacity
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
Fair Value ฿268.97 35.9% undervalued intrinsic discount
Digital Health And Medical Tourism Will Transform Southeast Asia Healthcare
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
New Cancer Center And Robotic Surgery Will Expand Global Capacity
Key Takeaways Expansion into advanced oncology, preventative medicine, and robotic surgery is strengthening high-margin service offerings and broadening the addressable market. Recovery in international patient flows and insurance partnerships is enhancing revenue diversification and supporting long-term earnings resilience.Read more
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
฿214.62
19.6% undervalued intrinsic discount
AnalystConsensusTarget Fair Value
Revenue growth
5.51% p.a.
Profit Margin
27.07%
Future PE
26.19x
Share price in 2028
฿266.11
Middle East Instability And Rising Wages Will Hurt Performance
Key Takeaways Heavy dependence on international medical tourists and geopolitical factors creates unpredictable revenue and heightens vulnerability to policy changes and travel restrictions. Intensifying regional competition, rising operational costs, and technological shifts threaten long-term growth, margins, and returns despite ongoing physical expansion.Read more
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
฿152
13.5% overvalued intrinsic discount
AnalystLowTarget Fair Value
Revenue growth
3.16% p.a.
Profit Margin
25.59%
Future PE
21.1x
Share price in 2028
฿188.36
Digital Health And Medical Tourism Will Transform Southeast Asia Healthcare
Key Takeaways Advanced cancer care, AI diagnostics, and wellness initiatives position Bumrungrad to dominate regional markets and deliver higher, recurring revenue with improved margins. Expansion into medical tourism centers and restoration of Gulf region partnerships will significantly broaden the international patient base and drive earnings growth.Read more
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AN
฿268.97
35.9% undervalued intrinsic discount
AnalystHighTarget Fair Value
Revenue growth
8.88% p.a.
Profit Margin
26.74%
Future PE
30.38x
Share price in 2028
฿333.31
Recently Updated Narratives
AN
New Cancer Center And Robotic Surgery Will Expand Global Capacity
Fair Value: ฿214.62 19.6% undervalued intrinsic discount
1 followerusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Middle East Instability And Rising Wages Will Hurt Performance
Fair Value: ฿152 13.5% overvalued intrinsic discount
0 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Digital Health And Medical Tourism Will Transform Southeast Asia Healthcare
Fair Value: ฿268.97 35.9% undervalued intrinsic discount
2 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Bumrungrad Hospital Public Company Limited Key Details
About BH
- Founded
- 1975
- Employees
- n/a
- CEO
- WebsiteView website
Bumrungrad Hospital Public Company Limited owns and operates hospitals in Thailand and internationally. It offers services in the areas of allergy, arrhythmia, behavioural health, breast, home, heart valve, robotic surgery, rehabilitation, spine, paediatrics, colorectal surgery, complex coronary artery intervention, comprehensive sleep, cornea transplant, dental, diagnostic, dialysis, radiology and nuclear medicine, digestive disease, ear, nose, throat, emergency, endocrinology, esperance, diabetes, expatriate liaison, eye, fertility, gastrointestinal motility, health screening, holistic wound care, horizon regional cancer, hyperbaric oxygen therapy, nephrology, neuroscience, orthopaedics, perinatal, plastic surgery, pulmonary, refractive surgery, memory, robotic scoliosis, skin, sports medicine and joint, surgery, travel medicine, urology, scientific wellness, skin and aesthetic, and women's centers. The company also operates breastfeeding, Yangon, COVID-19 recovery, IVF, hearing and balance, medical, new life healthy aging, Parkinson's disease and movement disorders, pride, surgery, and vaccine clinics and centers. In addition, it operates spine institute, heart institute, and intensive care unit; and offers nutrition services, pharmacy services, preventive genomics and integrative medicine services. Further, the company offers clinical research, hospital consulting and management, healthcare personnel development and training, healthcare referral, and digital platform services. Additionally, it is involved in the distribution of pharmaceutical and medical goods in specialized stores; development of software for healthcare services; holding of real estate assets; and manufacture and sale of vitamin supplements. Bumrungrad Hospital Public Company Limited was founded in 1975 and is based in Bangkok, Thailand.
